Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults

Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes

(2017) Ryan Vandrey et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Outcomes from a computer-assisted intervention simultaneously targeting cannabis and tobacco use

(2015) Dustin C. Lee et al.   DRUG AND ALCOHOL DEPENDENCE

Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use

(2015) Morris S. Odell et al.   FORENSIC SCIENCE INTERNATIONAL

Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013

(2015) Deborah S. Hasin et al.   JAMA Psychiatry

Achieving Cannabis Cessation — Evaluating N-acetylcysteine Treatment (ACCENT): Design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network

(2014) Erin A. McClure et al.   Contemporary Clinical Trials

Non-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results

(2014) Edward J. Cone et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Perceived Harm, Addictiveness, and Social Acceptability of Tobacco Products and Marijuana Among Young Adults: Marijuana, Hookah, and Electronic Cigarettes Win

(2014) Carla J. Berg et al.   SUBSTANCE USE & MISUSE

Testing for cannabis in the work-place: a review of the evidence

(2010) Scott Macdonald et al.   ADDICTION

Do Δ9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?

(2009) Erin L. Karschner et al.   ADDICTION